-
Something wrong with this record ?
Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations
GE. Conway, UK. Shah, S. Llewellyn, T. Cervena, SJ. Evans, AS. Al Ali, GJ. Jenkins, MJD. Clift, SH. Doak
Language English Country Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
G1000821
Medical Research Council - United Kingdom
NLK
Free Medical Journals
from 1996 to 1 year ago
Open Access Digital Library
from 1996-01-01
Medline Complete (EBSCOhost)
from 1996-01-01 to 1 year ago
- MeSH
- Aflatoxin B1 toxicity MeSH
- Models, Biological MeSH
- Cell Culture Techniques methods MeSH
- Cell Line MeSH
- Spheroids, Cellular * MeSH
- Hep G2 Cells MeSH
- Hepatocytes drug effects MeSH
- Liver drug effects MeSH
- Humans MeSH
- Methyl Methanesulfonate toxicity MeSH
- Micronucleus Tests methods MeSH
- Mutagens toxicity MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Following advancements in the field of genotoxicology, it has become widely accepted that 3D models are not only more physiologically relevant but also have the capacity to elucidate more complex biological processes that standard 2D monocultures are unable to. Whilst 3D liver models have been developed to evaluate the short-term genotoxicity of chemicals, the aim of this study was to develop a 3D model that could be used with the regulatory accepted in vitro micronucleus (MN) following low-dose, longer-term (5 days) exposure to engineered nanomaterials (ENMs). A comparison study was carried out between advanced models generated from two commonly used liver cell lines, namely HepaRG and HepG2, in spheroid format. While both spheroid systems displayed good liver functionality and viability over 14 days, the HepaRG spheroids lacked the capacity to actively proliferate and, therefore, were considered unsuitable for use with the MN assay. This study further demonstrated the efficacy of the in vitro 3D HepG2 model to be used for short-term (24 h) exposures to genotoxic chemicals, aflatoxin B1 (AFB1) and methyl-methanesulfonate (MMS). The 3D HepG2 liver spheroids were shown to be more sensitive to DNA damage induced by AFB1 and MMS when compared to the HepG2 2D monoculture. This 3D model was further developed to allow for longer-term (5 day) ENM exposure. Four days after seeding, HepG2 spheroids were exposed to Zinc Oxide ENM (0-2 µg/ml) for 5 days and assessed using both the cytokinesis-block MN (CBMN) version of the MN assay and the mononuclear MN assay. Following a 5-day exposure, differences in MN frequency were observed between the CBMN and mononuclear MN assay, demonstrating that DNA damage induced within the first few cell cycles is distributed across the mononucleated cell population. Together, this study demonstrates the necessity to adapt the MN assay accordingly, to allow for the accurate assessment of genotoxicity following longer-term, low-dose ENM exposure.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026560
- 003
- CZ-PrNML
- 005
- 20211026132813.0
- 007
- ta
- 008
- 211013s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/mutage/geaa018 $2 doi
- 035 __
- $a (PubMed)32780103
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Conway, Gillian E $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 245 10
- $a Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations / $c GE. Conway, UK. Shah, S. Llewellyn, T. Cervena, SJ. Evans, AS. Al Ali, GJ. Jenkins, MJD. Clift, SH. Doak
- 520 9_
- $a Following advancements in the field of genotoxicology, it has become widely accepted that 3D models are not only more physiologically relevant but also have the capacity to elucidate more complex biological processes that standard 2D monocultures are unable to. Whilst 3D liver models have been developed to evaluate the short-term genotoxicity of chemicals, the aim of this study was to develop a 3D model that could be used with the regulatory accepted in vitro micronucleus (MN) following low-dose, longer-term (5 days) exposure to engineered nanomaterials (ENMs). A comparison study was carried out between advanced models generated from two commonly used liver cell lines, namely HepaRG and HepG2, in spheroid format. While both spheroid systems displayed good liver functionality and viability over 14 days, the HepaRG spheroids lacked the capacity to actively proliferate and, therefore, were considered unsuitable for use with the MN assay. This study further demonstrated the efficacy of the in vitro 3D HepG2 model to be used for short-term (24 h) exposures to genotoxic chemicals, aflatoxin B1 (AFB1) and methyl-methanesulfonate (MMS). The 3D HepG2 liver spheroids were shown to be more sensitive to DNA damage induced by AFB1 and MMS when compared to the HepG2 2D monoculture. This 3D model was further developed to allow for longer-term (5 day) ENM exposure. Four days after seeding, HepG2 spheroids were exposed to Zinc Oxide ENM (0-2 µg/ml) for 5 days and assessed using both the cytokinesis-block MN (CBMN) version of the MN assay and the mononuclear MN assay. Following a 5-day exposure, differences in MN frequency were observed between the CBMN and mononuclear MN assay, demonstrating that DNA damage induced within the first few cell cycles is distributed across the mononucleated cell population. Together, this study demonstrates the necessity to adapt the MN assay accordingly, to allow for the accurate assessment of genotoxicity following longer-term, low-dose ENM exposure.
- 650 _2
- $a aflatoxin B1 $x toxicita $7 D016604
- 650 _2
- $a buněčné kultury $x metody $7 D018929
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a buňky Hep G2 $7 D056945
- 650 _2
- $a hepatocyty $x účinky léků $7 D022781
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a játra $x účinky léků $7 D008099
- 650 _2
- $a methylmethansulfonát $x toxicita $7 D008741
- 650 _2
- $a mikrojaderné testy $x metody $7 D015162
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a mutageny $x toxicita $7 D009153
- 650 12
- $a buněčné sféroidy $7 D018874
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Shah, Ume-Kulsoom $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 700 1_
- $a Llewellyn, Samantha $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 700 1_
- $a Cervena, Tereza $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK $u Department of Nanotoxicology and Molecular Epidemiology, Institute of Experimental Medicine of the CAS, Prague, Czech Republic
- 700 1_
- $a Evans, Stephen J $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 700 1_
- $a Al Ali, Abdullah S $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 700 1_
- $a Jenkins, Gareth J $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 700 1_
- $a Clift, Martin J D $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 700 1_
- $a Doak, Shareen H $u In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Singleton Park Campus, Swansea, Wales, UK
- 773 0_
- $w MED00003429 $t Mutagenesis $x 1464-3804 $g Roč. 35, č. 4 (2020), s. 319-330
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32780103 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132820 $b ABA008
- 999 __
- $a ok $b bmc $g 1715325 $s 1147067
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 35 $c 4 $d 319-330 $e 20200912 $i 1464-3804 $m Mutagenesis $n Mutagenesis $x MED00003429
- GRA __
- $a G1000821 $p Medical Research Council $2 United Kingdom
- LZP __
- $a Pubmed-20211013